Cenicriviroc Completed Phase 1 Trials for Hepatic Impairment Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03376841Impact of Severe Hepatic Impairment on Pharmacokinetics of Cenicriviroc and Its Metabolites